Re: Management of Peyronie's Disease with Collagenase Clostridium Histolyticum in the Acute Phase

被引:0
|
作者
El-Khatib, F. M. [1 ]
Towe, M. [1 ]
Yafi, F. A. [1 ]
机构
[1] Univ Calif Irvine, Dept Urol, Orange, CA 92668 USA
来源
JOURNAL OF UROLOGY | 2021年 / 205卷 / 01期
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:289 / 289
页数:1
相关论文
共 50 条
  • [31] COMPARISON OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM TO SURGERY FOR THE MANAGEMENT OF PEYRONIE'S DISEASE: A RANDOMIZED TRIAL
    Green, B.
    Francis, M.
    Savage, J.
    Brearton, K.
    Burgon, H.
    Tyler, A.
    Trost, L.
    JOURNAL OF SEXUAL MEDICINE, 2022, 19 (04): : S88 - S88
  • [32] OUTCOMES OF INTRALESIONAL COLLAGENASE CLOSTRIDIUM HISTOLYTICUM (CCH) IN PEYRONIE'S DISEASE
    Nascimento, B.
    Bernie, H. L.
    Miranda, E. P.
    Terrier, J.
    Taniguchi, H.
    Teloken, P.
    Mulhall, J. P.
    JOURNAL OF SEXUAL MEDICINE, 2019, 16 (04): : S131 - S132
  • [33] Collagenase clostridium histolyticum: a novel medical treatment for Peyronie's disease
    Raheem, Amr Abdel
    Johnson, Mark
    Ralph, David
    Garaffa, Giulio
    MINERVA UROLOGICA E NEFROLOGICA, 2018, 70 (04) : 380 - 385
  • [34] Clostridium histolyticum collagenase - is this a revolutionary medical treatment for Peyronie's disease?
    Poullis, Chris
    Shabbir, Majid
    Eardley, Ian
    Mulhall, John
    Minhas, Suks
    BJU INTERNATIONAL, 2016, 118 (02) : 186 - 189
  • [35] Re: Baseline Characteristics from an Ongoing Phase 3 Study of Collagenase Clostridium Histolyticum in Patients with Peyronie's Disease
    Dincer, Murat
    Serefoglu, Ege C.
    JOURNAL OF SEXUAL MEDICINE, 2014, 11 (05): : 1350 - 1350
  • [36] Re: Re: Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie's disease
    Tsambarlis, Peter
    Levine, Laurence A.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2020, 32 (02) : 257 - 258
  • [37] Re: Impact of the Advent of Collagenase Clostridium histolyticum on the Surgical Management of Peyronie's Disease: A Population-Based Analysis
    Seftel, Allen D.
    JOURNAL OF UROLOGY, 2020, 203 (06): : 1045 - 1045
  • [38] Re: Re: Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie’s disease
    Peter Tsambarlis
    Laurence A. Levine
    International Journal of Impotence Research, 2020, 32 : 257 - 258
  • [39] Reply: Comparison of Collagenase Clostridium histolyticum to Surgery for the Management of Peyronie's Disease: A Randomized Trial
    Trost, Landon
    JOURNAL OF UROLOGY, 2023, 211 (01):
  • [40] Intralesional injection of collagenase clostridium histolyticum for the management of Peyronie's disease with indentation or hourglass deformity
    Chung, E.
    Scott, S.
    BJU INTERNATIONAL, 2019, 123 : 37 - 38